PROFILE |
 |
Does the idea of a needle in your neck scare you? CardioDynamics International might be able to help. Its BioZ and BioZ.com systems give doctors a noninvasive way to gather cardiac data previously collected with the insertion of a catheter. The digital systems measure such cardiac activity as contraction strength and pumping capability by passing an electric current through the chest. Applications include hypertension, high-risk pregnancies, kidney dysfunction, and diabetes. The firm markets its products directly to doctor's offices, outpatient facilities, and, through distribution agreements, to hospitals in the US and more than 70 countries. J. Michael Paulson, a director, owns nearly a quarter of the company.
COMPETITION |
 |
Abbott Laboratories (ABT)
Cambridge Heart, Inc. (CAMH)
Welch Allyn Protocol, Inc. (dossier)
|
 |
STOCK ANALYSIS |
 |
FURTHER ANALYSIS
Advanced Charting
Deals
FINANCIAL OVERVIEW |
 |
Fiscal Year-End: November
2000 Sales (mil.): 13.10
1-Yr. Sales Growth: 79.5%
Employees: 109
Revenue per employee: $120,183.49
KEY PEOPLE |
 |
Michael K. Perry
CEO
Stephen P. Loomis
CFO
CONTACT INFO |
 |
6175 Nancy Ridge Dr., Ste. 300
San Diego, CA 92121
US
Phone: 858-535-0202
Fax: 858-535-0055
Online: Web Site
|